ArticleJournal of medicinal chemistry2024

Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor.

Xianglin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.